Gene · 833
NIH grants1,921
NIH grants whose papers are about the gene, through NIH's grant-paper links.
141 to 160 of 1,921
Download this page as JSON| Grant | Title | CARS1 papers | Newest fiscal year |
|---|---|---|---|
| ZIABC011415 | Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor | 2 | 2025 |
| ZIABC011743 | NIH Chronic GVHD Study Group | 2 | 2025 |
| ZIABC012066 | Development of new therapies for neuroblastoma | 2 | 2025 |
| ZIACL002119 | Develop novel assays for assessing cellular and gene therapies | 2 | 2025 |
| ZICBC010989 | Clinical production of viral vectors for cancer gene therapy | 2 | 2025 |
| ZIDSC007202 | Office of Collaborative Biostatistics | 2 | 2025 |
| D43TW009114 | Psychiatric research infrastructure for intervention and implementation in India – TEAMS | 1 | 2025 |
| DP2AI164319 | Engineering synthetic cellular crosstalk for transplantation tolerance | 1 | 2025 |
| DP5OD031863 | Discovering T cell proteome turnover dynamics to overcome the solid tumor microenvironment | 1 | 2025 |
| K08CA241088 | Functional epigenomics of transgenic cellular immunotherapies for cancer | 1 | 2025 |
| K08CA245181 | Targeting Radiation-Induced Myeloid Cells to Promote T cell Immunity in Undifferentiated Pleomorphic Sarcoma | 1 | 2025 |
| K08CA266824 | Investigating personalized approaches to de-intensify therapy for nodular lymphocyte-predominant Hodgkin lymphoma | 1 | 2025 |
| K08CA266930 | NOT-gated CAR T cells to overcome on-target, off-tumor toxicity in AML | 1 | 2025 |
| K08HL159350 | Informing national guidelines on adolescent and young adult physical activity and sedentary behavior to prevent cardiovascular disease | 1 | 2025 |
| K12GM081266 | The UCSF IRACDA Scholars Program. | 1 | 2025 |
| K12GM106996 | IRACDA at UCLA | 1 | 2025 |
| K12HD028820 | Advancing Child Health Through Cellular and Molecular Biology | 1 | 2025 |
| K23AI162249 | Clinical Pharmacology Approaches towards Accelerating HIV Cure Initiatives | 1 | 2025 |
| KL2TR001882 | Institutional Career Development Core | 1 | 2025 |
| KL2TR002346 | Washington University Institute of Clinical and Translational Sciences (KL2) | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/833/grants?page=8